Proteopedia:Featured SEL/1: Difference between revisions
Avian Influenza Neuraminidase |
image must be a link |
||
(5 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
<table> | <table> | ||
<tr><td> | <tr><td> | ||
<tr><td>'''Avian Influenza Neuraminidase'''< | <imagemap> | ||
Image:Anim Avian Influenza Neuraminidase.gif | |||
default [[Avian_Influenza_Neuraminidase,_Tamiflu_and_Relenza]] | |||
</imagemap> | |||
</td></tr> | |||
<tr><td><div class='scrolling'>'''Avian Influenza Neuraminidase'''<br> | |||
''Eric Martz''<br> | |||
The first new influenza virus to emerge as an imminent pandemic threat in the 21st century is H1N1 swine flu. The drug '''oseltamivir''' (Tamiflu®) inhibits flu neuraminidase, a component necessary for virus spread, in susceptible flu strains. The development of oseltamivir was guided, in part, by crystallographically determined structures of flu neuraminidase, which is a homotetramer, shown with oseltamivir bound. Oseltamivir was designed to fit N2/N9 (neuraminidases from other strains of flu). Serendipitously, it also fits N1 by induced fit. | |||
>>> [[Avian_Influenza_Neuraminidase%2C_Tamiflu_and_Relenza|Visit this page]] >>> | |||
</div> | |||
</td></tr> | </td></tr> | ||
</table> | </table> | ||
[[Category:Featured in Selected Pages]] |